nach oben

Acta Diabetologica

Erschienen in:

14.03.2017 | Review Article

Why should people with type 1 diabetes exercise regularly?

verfasst von: Roberto Codella, Ileana Terruzzi, Livio Luzi

Erschienen in: Acta Diabetologica | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Plethoric evidence reminds of the protective effects of exercise against a number of health risks, across all ages, in the general population. The benefits of exercise for individuals with type 2 diabetes are indisputable. An in-depth understanding of energy metabolism has reasonably entailed exercise as a cornerstone in the lifestyle of almost all subjects with type 1 diabetes. Nevertheless, individuals with type 1 diabetes often fail in accomplishing exercise guidelines and they are less active than their peer without diabetes. Two major obstacles are feared by people with type 1 diabetes who wish to exercise regularly: management of blood glucose control and hypoglycemia. Nowadays, strategies, including glucose monitoring technology and insulin pump therapy, have significantly contributed to the participation in regular physical activity, and even in competitive sports, for people with type 1 diabetes. Novel modalities of training, like different intensity, interspersed exercise, are as well promising. The beneficial potential of exercise in type 1 diabetes is multi-faceted, and it has to be fully exploited because it goes beyond the insulin-mimetic action, possibly through immunomodulation.

Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663–1672PubMedCrossRef

Codella R, Lanzoni G, Zoso A et al (2015) Moderate intensity training impact on the inflammatory status and glycemic profiles in NOD mice. J Diabetes Res. doi:10.1155/2015/737586

Luzi L, Codella R, Lauriola V et al (2011) Immunomodulatory effects of exercise in type 1 diabetes mellitus. Diabetes 60:A209–A210CrossRef

Codella R, Luzi L, Inverardi L, Ricordi C (2015) The anti-inflammatory effects of exercise in the syndromic thread of diabetes and autoimmunity. Eur Rev Med Pharmacol Sci 19:3709–3722PubMed

Delmonte V, Peixoto EML, Poggioli R et al (2013) Ten years’ evaluation of diet, anthropometry, and physical exercise adherence after islet allotransplantation. Transpl Proc 45:2025–2028. doi:10.1016/j.transproceed.2013.01.031 CrossRef

Adamo M, Codella R, Casiraghi F et al (2017) Active subjects with autoimmune type 1 diabetes have better metabolic profiles than sedentary controls. Cell Transpl 26(1):23–32CrossRef

Delmonte V, Codella R, Piemonti L et al (2014) Effects of exercise in a islet-transplanted half-marathon runner: outcome on diabetes management, training and metabolic profile. Sport Sci Health 10:49–52. doi:10.1007/s11332-013-0164-7 CrossRef

Codella R, Adamo M, Maffi P et al (2016) Ultra-marathon 100 km in an islet-transplanted runner. Acta Diabetol. doi:10.1007/s00592-016-0938-x PubMed

Fischer CP (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12:6–33PubMed

10.

Ellingsgaard H, Ehses JA, Hammar EB et al (2008) Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci USA 105:13163–13168. doi:10.1073/pnas.0801059105 PubMedPubMedCentralCrossRef

11.

Ellingsgaard H, Hauselmann I, Schuler B et al (2011) Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17:1481–1489. doi:10.1038/nm.2513 PubMedPubMedCentralCrossRef

12.

da Silva Krause M, Bittencourt A, Homem de Bittencourt PI et al (2012) Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic β-cell line and mouse islets. J Endocrinol 214:301–311. doi:10.1530/JOE-12-0223 CrossRef

13.

Suzuki T, Imai J, Yamada T et al (2011) Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes 60:537–547. doi:10.2337/db10-0796 PubMedPubMedCentralCrossRef

14.

Codella R, Terruzzi I, Luzi L (2016) Sugars, exercise and health. J Affect Disord. doi:10.1016/j.jad.2016.10.035 PubMed

15.

Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL (2001) Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal-bolus insulin regimen (ultralente-lispro). Diabetes Care 24:625–630. doi:10.2337/diacare.24.4.625 PubMedCrossRef

16.

Dubé MC, Weisnagel SJ, Prud’homme D, Lavoie C (2005) Exercise and newer insulins: How much glucose supplement to avoid hypoglycemia? Med Sci Sports Exerc 37:1276–1282. doi:10.1249/01.mss.0000174950.25188.36 PubMedCrossRef

17.

Yardley JE, Iscoe KE, Sigal RJ et al (2013) Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients. Diabetes Technol Ther. doi:10.1089/dia.2012.0168

18.

Cryer PE (2010) Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am 39:641–654. doi:10.1016/j.ecl.2010.05.003 PubMedPubMedCentralCrossRef

19.

Cryer PE (2008) The barrier of hypoglycemia in diabetes. Diabetes 57:3169–3176. doi:10.2337/db08-1084 PubMedPubMedCentralCrossRef

20.

Davis SN, Mann S, Galassetti P et al (2000) Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans. Diabetes 49:1897–1903. doi:10.2337/diabetes.49.11.1897 PubMedCrossRef

21.

Galassetti P, Tate D, Neill RA et al (2003) Effect of antecedent hypoglycemia on counterregulatory responses to subsequent euglycemic exercise in type 1 diabetes. Diabetes 52:1761–1769. doi:10.2337/diabetes.52.7.1761 PubMedCrossRef

22.

Lewis GD, Farrell L, Wood MJ et al (2010) Metabolic signatures of exercise in human plasma. Sci Transl Med 2:33–37. doi:10.1126/scitranslmed.3001006 CrossRef

23.

Brugnara L, Vinaixa M, Murillo S et al (2012) Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. PLoS ONE. doi:10.1371/journal.pone.0040600 PubMedPubMedCentral

24.

Chatzinikolaou A, Fatouros I, Petridou A et al (2008) Adipose tissue lipolysis is upregulated in lean and obese men during acute resistance exercise. Diabetes Care 31:1397–1399. doi:10.2337/dc08-0072 PubMedPubMedCentralCrossRef

25.

Davison GW, George L, Jackson SK et al (2002) Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus. Free Radic Biol Med 33:1543–1551PubMedCrossRef

26.

Jia G, DeMarco VG, Sowers JR (2015) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12:144–153. doi:10.1038/nrendo.2015.216 PubMedPubMedCentralCrossRef

27.

Kaul K, Apostolopoulou M, Roden M (2015) Insulin resistance in type 1 diabetes mellitus. Metabolism 64:1629–1639. doi:10.1016/j.metabol.2015.09.002 PubMedCrossRef

28.

Schauer IE, Snell-Bergeon JK, Bergman BC et al (2011) Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: the CACTI study. Diabetes 60:306–314. doi:10.2337/db10-0328 PubMedCrossRef

29.

Caprio S, Amiel S, Tamborlane WV et al (1990) Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control. Diabetes 39:134–141PubMedCrossRef

30.

Bergman BC, Howard D, Schauer IE et al (2012) Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes. J Clin Endocrinol Metab 97:1663–1672. doi:10.1210/jc.2011-3172 PubMedPubMedCentralCrossRef

31.

Nadeau KJ, Regensteiner JG, Bauer TA et al (2010) Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab 95:513–521. doi:10.1210/jc.2009-1756 PubMedCrossRef

32.

Perseghin G, Lattuada G, Danna M et al (2003) Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 285:E1174–E1181. doi:10.1152/ajpendo.00279.2003 PubMedCrossRef

33.

Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H (2001) Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia 44:824–833. doi:10.1007/s001250100545 PubMedCrossRef

34.

Caprio S, Napoli R, Saccà L et al (1992) Impaired stimulation of gluconeogenesis during prolonged hypoglycemia in intensively treated insulin-dependent diabetic subjects. J Clin Endocrinol Metab 75:1076–1080. doi:10.1210/jcem.75.4.1400874 PubMed

35.

Siafarikas A, Johnston RJ, Bulsara MK et al (2012) Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care 35:1757–1762. doi:10.2337/dc11-2010 PubMedPubMedCentralCrossRef

36.

Popp DA, Shah SD, Cryer PE (1982) Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus. J Clin Invest 69:315–326. doi:10.1172/jci110455 PubMedPubMedCentralCrossRef

37.

Hoffman RP (2007) Sympathetic mechanisms of hypoglycemic counterregulation. Curr Diabetes Rev 3:185–193PubMedCrossRef

38.

Tesfaye N, Seaquist ER (2010) Neuroendocrine responses to hypoglycemia. Ann N Y Acad Sci 1212:12–28. doi:10.1111/j.1749-6632.2010.05820.x PubMedPubMedCentralCrossRef

39.

Sprague JE, Arbeláez AM (2011) Glucose counterregulatory responses to hypoglycemia. Pediatr Endocrinol Rev 9:463–73; quiz 474–5

40.

Wasserman DH (2009) Four grams of glucose. Am J Physiol Endocrinol Metab 296:E11–E21. doi:10.1152/ajpendo.90563.2008 PubMedCrossRef

41.

Camacho RC, Galassetti P, Davis SN, Wasserman DH (2005) Glucoregulation during and after exercise in health and insulin-dependent diabetes. Exerc Sport Sci Rev 33:17–23PubMed

42.

Mallad A, Hinshaw L, Schiavon M et al (2015) Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach. Am J Physiol Endocrinol Metab 308:E1106–E1115. doi:10.1152/ajpendo.00014.2015 PubMedPubMedCentralCrossRef

43.

Chokkalingam K, Tsintzas K, Snaar JEM et al (2007) Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study. Diabetologia 50:1921–1929. doi:10.1007/s00125-007-0747-4 PubMedCrossRef

44.

Schneider SH, Vitug A, Ananthakrishnan R, Khachadurian AK (1991) Impaired adrenergic response to prolonged exercise in type I diabetes. Metabolism 40:1219–1225. doi:10.1016/0026-0495(91)90219-M PubMedCrossRef

45.

Kacerovsky M, Jones J, Schmid AI et al (2011) Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes 60:1752–1758. doi:10.2337/db10-1001 PubMedPubMedCentralCrossRef

46.

McMahon SK, Ferreira LD, Ratnam N et al (2007) Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab 92:963–968. doi:10.1210/jc.2006-2263 PubMedCrossRef

47.

The Diabetes Research in Children E, Mauras N, Beck RW et al (2005) Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 147:528–534. doi:10.1016/j.jpeds.2005.04.065 CrossRef

48.

Taplin CE, Cobry E, Messer L et al (2010) Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr 157(784–788):e1. doi:10.1016/j.jpeds.2010.06.004

49.

Iscoe KE, Corcoran M, Riddell MC (2008) High rates of nocturnal hypoglycemia in a unique sports camp for athletes with type 1 diabetes: lessons learned from continuous glucose monitoring systems. Can J Diabetes 32:182–189. doi:10.1016/S1499-2671(08)23008-X CrossRef

50.

Iscoe KE, Campbell JE, Jamnik V et al (2006) Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther 8:627–635. doi:10.1089/dia.2006.8.627 PubMedCrossRef

51.

The DR in CNSG (2005) Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 147:528–534. doi:10.1016/j.jpeds.2005.04.065 CrossRef

52.

Maran A, Pavan P, Bonsembiante B et al (2010) Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther 12:763–768. doi:10.1089/dia.2010.0038 PubMedCrossRef

53.

American Diabetes Association (2014) Standards of medical care in diabetes–2014. Diabetes Care 37:S14–S80. doi:10.2337/dc14-S014 CrossRef

54.

Benedini S, Longo S, Caumo A et al (2012) Metabolic and hormonal responses to a single session of kumite (free non-contact fight) and kata (highly ritualized fight) in karate athletes. Sport Sci Health 8:81–85. doi:10.1007/s11332-012-0132-7 PubMedPubMedCentralCrossRef

55.

Delvecchio M, Zecchino C, Salzano G et al (2009) Effects of moderate-severe exercise on blood glucose in Type 1 diabetic adolescents treated with insulin pump or glargine insulin. J Endocrinol Invest 32:519–524. doi:10.1007/BF03346499 PubMedCrossRef

56.

Marliss EB, Vranic M (2002) Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes. doi:10.2337/diabetes.51.2007.S271 PubMed

57.

Robertson K, Adolfsson P, Scheiner G et al (2009) Exercise in children and adolescents with diabetes. Pediatr Diabetes 10:154–168. doi:10.1111/j.1399-5448.2009.00567.x PubMedCrossRef

58.

Riddell MC, Sigal RJ (2013) Physical activity, exercise and diabetes. Can J Diabetes 37:359–360. doi:10.1016/j.jcjd.2013.10.001 PubMedCrossRef

59.

Gibney J, Healy M-L, Sönksen PH (2007) The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocr Rev 28:603–624. doi:10.1210/er.2006-0052 PubMedCrossRef

60.

Pritzlaff CJ, Wideman L, Blumer J et al (2000) Catecholamine release, growth hormone secretion, and energy expenditure during exercise vs. recovery in men. J Appl Physiol 89:937–946PubMed

61.

Pritzlaff-Roy CJ, Widemen L, Weltman JY et al (2002) Gender governs the relationship between exercise intensity and growth hormone release in young adults. J Appl Physiol 92:2053–2060. doi:10.1152/japplphysiol.01018.2001 PubMedCrossRef

62.

Wideman L, Weltman JY, Hartman ML et al (2002) Growth hormone release during acute and chronic aerobic and resistance exercise: recent findings. Sports Med 32:987–1004PubMedCrossRef

63.

Brooks G (2009) Cell–cell and intracellular lactate shuttles. J Physiol 587:5591–5600. doi:10.1113/jphysiol.2009.178350 PubMedPubMedCentralCrossRef

64.

Harmer AR, Chisholm DJ, McKenna MJ et al (2008) Sprint training increases muscle oxidative metabolism during high-intensity exercise in patients with type 1 diabetes. Diabetes Care 31:2097–2102. doi:10.2337/dc08-0329 PubMedPubMedCentralCrossRef

65.

Fahey AJ, Paramalingam N, Davey RJ et al (2012) The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. J Clin Endocrinol Metab 97:4193–4200. doi:10.1210/jc.2012-1604 PubMedCrossRef

66.

Bussau VA, Ferreira LD, Jones TW, Fournier PA (2006) The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes. Diabetes Care 29:601–606PubMedCrossRef

67.

Bussau VA, Ferreira LD, Jones TW, Fournier PA (2007) A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes. Diabetologia 50:1815–1818. doi:10.1007/s00125-007-0727-8 PubMedCrossRef

68.

Yardley JE, Kenny GP, Perkins BA et al (2012) Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care 35:669–675. doi:10.2337/dc11-1844 PubMedPubMedCentralCrossRef

69.

Guelfi KJ, Ratnam N, Smythe GA et al (2007) Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. Am J Physiol Endocrinol Metab 292:E865–E870. doi:10.1152/ajpendo.00533.2006 PubMedCrossRef

70.

Iscoe KE, Riddell MC (2011) Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with Type 1 diabetes mellitus. Diabet Med 28:824–832. doi:10.1111/j.1464-5491.2011.03274.x PubMedCrossRef

71.

Bally L, Zueger T, Buehler T et al (2016) Metabolic and hormonal response to intermittent high-intensity and continuous moderate intensity exercise in individuals with type 1 diabetes: a randomised crossover study. Diabetologia 59:776–784. doi:10.1007/s00125-015-3854-7 PubMedCrossRef

72.

Davey RJ, Jones TW, Fournier PA (2010) Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. J Diabetes Sci Technol 4:1457–1464PubMedPubMedCentralCrossRef

73.

Bally L, Zueger T, Pasi N et al (2016) Accuracy of continuous glucose monitoring during differing exercise conditions. Diabetes Res Clin Pract 112:1–5. doi:10.1016/j.diabres.2015.11.012 PubMedCrossRef

74.

Home PD, Meneghini L, Wendisch U et al (2012) Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes. Diabet Med 29:716–720. doi:10.1111/j.1464-5491.2011.03547.x PubMedPubMedCentralCrossRef

75.

Nasrallah SN, Nasrallah LR, Raymond Reynolds L (2012) Insulin degludec, the new generation basal insulin or just another basal insulin? Clin Med Insights Endocrinol Diabetes 5:31. doi:10.4137/CMED.S9494 PubMedPubMedCentralCrossRef

76.

Pellegrini S, Cantarelli E, Sordi V et al (2016) The state of the art of islet transplantation and cell therapy in type 1 diabetes. Acta Diabetol 53:683–691. doi:10.1007/s00592-016-0847-z PubMedCrossRef

77.

Hering BJ, Clarke WR, Bridges ND et al (2016) Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia. Diabetes Care 39:1230–1240. doi:10.2337/dc15-1988 PubMedCrossRef

78.

79.

Boehncke S, Poettgen K, Maser-Gluth C et al (2009) Endurance capabilities of triathlon competitors with type 1 diabetes mellitus. Dtsch Med Wochenschr 134:677–682. doi:10.1055/s-0029-1208104 PubMedCrossRef

80.

Komatsu WR, Gabbay MAL, Castro ML et al (2005) Aerobic exercise capacity in normal adolescents and those with type 1 diabetes mellitus. Pediatr Diabetes 6:145–149. doi:10.1111/j.1399-543X.2005.00120.x PubMedCrossRef

81.

Levy BI, Schiffrin EL, Mourad J-J et al (2008) Impaired Tissue Perfusion. Circulation 118:968PubMedCrossRef

82.

Kivelä R, Silvennoinen M, Touvra A-M et al (2006) Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J 20:1570–1572. doi:10.1096/fj.05-4780fje PubMedCrossRef

83.

Krause MP, Riddell MC, Hawke TJ (2011) Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms. Pediatr Diabetes 12:345–364. doi:10.1111/j.1399-5448.2010.00699.x PubMedCrossRef

84.

Chiang JL, Kirkman MS, Laffel LMB et al (2014) Type 1 Diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 37:2034–2054. doi:10.2337/dc14-1140 PubMedCrossRef

85.

Colberg SR, Sigal RJ, Yardley JE et al (2016) Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 39:2065–2079. doi:10.2337/dc16-1728 PubMedCrossRef

86.

Yardley JE, Kenny GP, Perkins B et al (2013) Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes. Diabetes Care 36:537–542. doi:10.2337/dc12-0963 PubMedPubMedCentralCrossRef

87.

Almeida S, Riddell MC, Cafarelli E (2008) Slower conduction velocity and motor unit discharge frequency are associated with muscle fatigue during isometric exercise in type 1 diabetes mellitus. Muscle Nerve 37:231–240. doi:10.1002/mus.20919 PubMedCrossRef

88.

Magee MF, Bhatt BA (2001) Management of decompensated diabetes. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Crit Care Clin 17:75–106PubMedCrossRef

89.

Horton WB, Subauste JS (2016) Care of the athlete with type 1 diabetes mellitus: a clinical review. Int J Endocrinol Metab 14:e36091. doi:10.5812/ijem.36091 PubMedPubMedCentral

90.

Gallen IW, Hume C, Lumb A (2011) Fuelling the athlete with type 1 diabetes. Diabetes Obes Metab 13:130–136. doi:10.1111/j.1463-1326.2010.01319.x PubMedCrossRef

91.

Andersen H, Poulsen PL, Mogensen CE, Jakobsen J (1996) Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes 45:440–445PubMedCrossRef

92.

Andreassen CS, Jakobsen J, Ringgaard S et al (2009) Accelerated atrophy of lower leg and foot muscles–a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia 52:1182–1191. doi:10.1007/s00125-009-1320-0 PubMedCrossRef

93.

Campbell MD, Walker M, Bracken RM et al (2015) Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 3:e000085–e000085. doi:10.1136/bmjdrc-2015-000085 PubMedPubMedCentralCrossRef

94.

McAuley SA, Horsburgh JC, Ward GM et al (2016) Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study. Diabetologia. doi:10.1007/s00125-016-3981-9 PubMed

95.

Sherr JL, Cengiz E, Palerm CC et al (2013) Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nightswith or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care. doi:10.2337/dc13-0010

96.

Martínez-Ramonde T, Alonso N, Cordido F et al (2014) Importance of exercise in the control of metabolic and inflammatory parameters at the moment of onset in type 1 diabetic subjects. Exp Clin Endocrinol Diabetes 122:334–340. doi:10.1055/s-0034-1372581 PubMedCrossRef

97.

Davey RJ, Howe W, Paramalingam N et al (2013) The effect of midday moderate-intensity exercise on postexercise hypoglycemia risk in individuals with type 1 diabetes. J Clin Endocrinol Metab 98:2908–2914. doi:10.1210/jc.2013-1169 PubMedCrossRef

98.

Tunar M, Ozen S, Goksen D et al (2012) The effects of Pilates on metabolic control and physical performance in adolescents with type 1 diabetes mellitus. J Diabetes Complications 26:348–351. doi:10.1016/j.jdiacomp.2012.04.006 PubMedCrossRef

99.

Yardley JE, Kenny GP, Perkins BA et al (2015) Resistance exercise in already-active diabetic individuals (READI): study rationale, design and methods for a randomized controlled trial of resistance and aerobic exercise in type 1 diabetes. Contemp Clin Trials 41:129–138. doi:10.1016/j.cct.2014.12.017 PubMedCrossRef

100.

Shetty VB, Fournier PA, Davey RJ et al (2016) Effect of exercise intensity on glucose requirements to maintain euglycemia during exercise in type 1 diabetes. J Clin Endocrinol Metab 101:972–980. doi:10.1210/jc.2015-4026 PubMedCrossRef

101.

Davey RJ, Bussau VA, Paramalingam N et al (2013) A 10-s sprint performed after moderate-intensity exercise neither increases nor decreases the glucose requirement to prevent late-onset hypoglycemia in individuals with type 1 diabetes. Diabetes Care 36:4163–4165. doi:10.2337/dc12-2198 PubMedPubMedCentralCrossRef

102.

Komatsu WR, Barros Neto TL, Chacra AR, Dib S (2010) Aerobic exercise capacity and pulmonary function in athletes with and without type 1 diabetes. Diabetes Care 33:2555–2557. doi:10.2337/dc10-0769 PubMedPubMedCentralCrossRef

103.

Veves A, Saouaf R, Donaghue VM et al (1997) Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes 46:1846–1852PubMedCrossRef

104.

Gusso S, Hofman P, Lalande S et al (2008) Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus. Diabetologia 51:1317–1320. doi:10.1007/s00125-008-1012-1 PubMedCrossRef

105.

Salem MA, AboElAsrar MA, Elbarbary NS et al (2010) Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial. Diabetol Metab Syndr 2:47. doi:10.1186/1758-5996-2-47 PubMedPubMedCentralCrossRef

106.

Herbst A, Kordonouri O, Schwab KO et al (2007) Impact of physical activity on cardiovascular risk factors in children with type 1 diabetes: a multicenter study of 23,251 patients. Diabetes Care 30:2098–2100. doi:10.2337/dc06-2636 PubMedCrossRef

107.

Huber J, Fröhlich-Reiterer EE, Sudi K et al (2010) The influence of physical activity on ghrelin and IGF-1/IGFBP-3 levels in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 11:383–385. doi:10.1111/j.1399-5448.2009.00604.x PubMedCrossRef

108.

Laaksonen DE, Atalay M, Niskanen LK et al (2000) Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial. Med Sci Sports Exerc 32:1541–1548PubMedCrossRef

109.

Dubé MC, Joanisse DR, Prud’homme D et al (2006) Muscle adiposity and body fat distribution in type 1 and type 2 diabetes: varying relationships according to diabetes type. Int J Obes 30:1721–1728. doi:10.1038/sj.ijo.0803337 CrossRef

110.

Kennedy A, Nirantharakumar K, Chimen M et al (2013) Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. PLoS ONE. doi:10.1371/journal.pone.0058861

111.

Bohn B, Herbst A, Pfeifer M et al (2015) Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients. Diabetes Care 38:1536–1543. doi:10.2337/dc15-0030 PubMedCrossRef

112.

Quirk H, Blake H, Tennyson R et al (2014) Physical activity interventions in children and young people with Type 1 diabetes mellitus: a systematic review with meta-analysis. Diabet Med 31:1163–1173. doi:10.1111/dme.12531 PubMedPubMedCentralCrossRef

113.

Avogaro A, Gnudi L, Valerio A et al (1993) Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects. J Clin Endocrinol Metab 76:845–850. doi:10.1210/jcem.76.4.8473394 PubMed

114.

da Silva Krause M, de Bittencourt PIH (2008) Type 1 diabetes: can exercise impair the autoimmune event? TheL-arginine/glutamine coupling hypothesis. Cell Biochem Funct 26:406–433. doi:10.1002/cbf.1470 CrossRef

115.

Codella R, Luzi L, Inverardi L, Ricordi C (2015) The anti-inflammatory effects of exercise in the syndromic thread of diabetes and autoimmunity. Eur Rev Med Pharmacol Sci 19:3709–3722PubMed

116.

Galassetti P, Riddell MC (2013) Exercise and type 1 diabetes (T1DM). Compr Physiol 3:1309–1336. doi:10.1002/cphy.c110040 PubMed

117.

Pedersen BK, Saltin B (2015) Exercise as medicine—Evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sport. doi:10.1111/sms.12581

118.

West DJ, Campbell MD, Gonzalez JT et al (2015) The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study. Cardiovasc Diabetol 14:71. doi:10.1186/s12933-015-0235-y PubMedPubMedCentralCrossRef

119.

Steppel JH, Horton ES (2003) Exercise in the management of type 1 diabetes mellitus. Rev Endocr Metab Dis 4:355–369. doi:10.1023/A:1027302112655 CrossRef

Titel: Why should people with type 1 diabetes exercise regularly?
verfasst von: Roberto Codella
Ileana Terruzzi
Livio Luzi
Publikationsdatum: 14.03.2017
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 7/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-017-0978-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2017

Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK/SREBP-1c pathway in skeletal muscle cells exposed to palmitate

Immunoevasion rather than intrinsic oncogenicity may confer MSCs from non-obese diabetic mice the ability to generate neural tumors

Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy

Erratum to: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation

Toward molecular imaging of the free fatty acid receptor 1